IKZF1 Deletions Are Markers of Treatment Resistance in Adult Ph-Negative B-Cell Acute Lymphoblastic Leukemia Patients Treated within the Ongoing Risk-Adapted Pethema LAL19 Trial
Autor: | Ribera, Jordi *, Granada, Isabel *, González, Teresa *, Morgades, Mireia *, Garcia, Olga *, Sanchez, Ricardo *, Such, Esperanza *, Barrena, Susana *, Ciudad, Juana *, Soriano, Beatriz *, Benito, Rocio *, Avetisyan, Gayane *, Lumbreras, Eva *, Miguel-García, Cristina *, Santos-Mínguez, Sandra *, Zamora, Lurdes *, Mallo, Mar *, González-Gil, Celia *, Genescà, Eulàlia *, Lopes, Thaysa *, Hernández-Rivas, Jesus Maria, Orfao, Alberto, Ribera, Josep-Maria |
---|---|
Zdroj: | In Blood 15 November 2022 140 Supplement 1:6345-6347 |
Databáze: | ScienceDirect |
Externí odkaz: |